Table 2 Clinical information, morphologic classification, and immunophenotypic characteristics of the 32 patients

From: Expression of HGAL in primary cutaneous large B-cell lymphomas: evidence for germinal center derivation of primary cutaneous follicular lymphoma

Patients

Morph. Dx.

Site

Age (years)

Sex

F/U month

Status

CD20

BCL2

BCL6

MUM-1

CD10

HGAL

GCB a

 1

DLBCL-LT

Leg

92

F

54

Alive

3

Pos

Pos

Pos

Pos

NA

Y

 2

DLBCL-LT

Scalp

90

F

85

Deceased

3

Pos

Neg

Pos

Neg

Neg

N

 3

DLBCL-LT

Leg

80

F

18

Deceased

3

Pos

Neg

Pos

Neg

Pos

N

 4

DLBCL-LT

Leg

41

F

26

Deceased

3

Pos

Neg

Neg

Pos

Pos

N

 5

DLBCL-LT

Leg

74

F

34

Alive

3

Pos

Pos

Pos

Pos

Neg

N

 6

DLBCL-LT

Leg

84

F

24

Alive

3

Pos

Neg

Neg

Neg

Neg

N

 7

DLBCL-LT

Leg

89

F

6

Alive

3

Pos

Neg

Pos

Neg

Neg

N

 8

DLBCL-LT

Leg

81

F

7

Deceased

2

Pos

Neg

Pos

Neg

Neg

N

 9

DLBCL-LT

Leg

72

F

24

Alive

3

Pos

Pos

Pos

Neg

Neg

N

10

DLBCL-LT

Leg

83

F

36

Alive

3

Pos

Neg

Pos

Neg

Pos

N

11

PCFCL

Back

68

F

64

Alive

3

Pos

Pos

Neg

Pos

Pos

Y

12

PCFCL

Scalp

49

M

3

Alive

3

Neg

Pos

Neg

Pos

Pos

Y

13

PCFCL

Scalp

62

F

33

Alive

3

Pos

Pos

Pos

Neg

Neg

N

14

PCFCL

Nasal

52

F

42

Alive

3

Neg

Pos

Pos

Neg

Pos

N

15

PCFCL

Chest

56

M

56

Alive

3

Neg

Pos

Neg

Neg

Pos

Y

16

PCFCL

Shoulder

71

F

NA

NA

3

Neg

Pos

Neg

Pos

NA

Y

17

PCFCL

Abdomen

17

F

NA

NA

3

Pos

Pos

Pos

Pos

Pos

Y

18

PCFCL

Scalp

30

M

61

Alive

3

Neg

Pos

Pos

Pos

NA

Y

19

PCFCL

Back

77

M

NA

NA

3

Neg

Pos

Pos

Neg

NA

N

20

PCFCL

Scalp

56

M

11

Alive

3

Neg

Pos

Pos

Neg

NA

N

21

PCFCL

Scalp

46

M

9

Alive

3

Neg

Pos

Neg

Neg

Pos

Y

22

PCFCL

Back

78

M

7

Alive

3

Pos

Pos

Pos

Pos

NA

Y

23

PCFCL

Scalp

37

M

205

Alive

3

Neg

Pos

Pos

Neg

Pos

Y

24

PCFCL

Face

65

F

4

Deceased

3

Neg

Pos

Neg

Neg

Pos

Y

25

PCFCL

Scalp

61

M

16

Alive

3

Neg

Pos

Pos

Neg

Pos

Y

26

PCFCL

Buttock

60

F

176

Deceased

3

Neg

Pos

Neg

Neg

Pos

N

27

PCFCL

Back

41

M

245

Alive

3

Neg

Pos

Neg

Neg

Pos

N

28

PCFCL

Back

69

F

14

Alive

3

Pos

Pos

Pos

Neg

Neg

N

29

PCFCL

Chest

58

M

166

Alive

3

Pos

Pos

Neg

Pos

Pos

N

30

PCFCL

Arm

64

M

94

Alive

3

Pos

Pos

Pos

Neg

Pos

Y

31

PCFCL

Hip

50

M

53

Alive

3

Pos

Pos

Neg

Neg

Pos

N

32

PCFCL

Back

36

M

155

Alive

3

Pos

Pos

Neg

Neg

Pos

Y

  1. aGCB (germinal center B cell) status is determined using Han et al's7 criteria using 30% as the cutoff.